TALLAHASSEE -- Advanced computer power is helping a Florida State University researcher assess the cancer-fighting abilities of a new class of drugs. Kevin C. Chen, an assistant professor of chemical and biomedical engineering at the Florida A&M University-Florida State University College of Engineering, is using computational analysis to determine how substances known as recombinant immunotoxins can best be modified in order to attack and kill malignant tumors while doing minimal harm to a patient's healthy cells. ...more

July 9, 2008

A researcher who has been experimenting with monoclonal antibodies as a tool for fighting cancer for almost two decades says she has developed a form of the cloned immune system component that could play a role in treating breast, ovarian and other forms of cancer. ...more

May 28, 2008